Similar articles

• A phase II study of aclacinomycin A in acute leukemia in adults.

  Yamada K, Nakamura T, Tsuruo T, Kitahara T, Maekawa T, Uzaka Y, Kurita S, Masaoka T, Takaku F, Hirota Y, Amaki I, Osamura S, Ito M, Nakano N, Oguro M, Inagaki J, Onozawa K. Yamada K, et al. Cancer Treat Rev. 1980 Dec;7(4):177-82. doi: 10.1016/s0305-7372(80)80033-8. Cancer Treat Rev. 1980. PMID: 6938305 No abstract available.
• Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.

  Mathé G, Bayssas M, Gouveia J, Dantchev D, Ribaud P, Machover D, Misset JL, Schwarzenberg L, Jasmin C, Hayat M. Mathé G, et al. Cancer Chemother Pharmacol. 1978;1(4):259-62. doi: 10.1007/BF00257160. Cancer Chemother Pharmacol. 1978. PMID: 373923 Clinical Trial.
• [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].

  Mathé G, de Jager R, Hulhoven R, Delgado M, Machover D, Ribaud P, de Vassal F, Gil-Delgado M, Misset JL, Gouveia J, Jasmin C, Hayat M, Gastiaburu J, Schwarzenberg L. Mathé G, et al. Nouv Presse Med. 1982 Jan 9;11(1):25-8. Nouv Presse Med. 1982. PMID: 6949137 French.
• Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.

  Oki T, Takeuchi T, Oka S, Umezawa H. Oki T, et al. Recent Results Cancer Res. 1980;74:207-16. doi: 10.1007/978-3-642-81488-4_26. Recent Results Cancer Res. 1980. PMID: 7003659 Review.
• The anthracycline antineoplastic drugs.

  Young RC, Ozols RF, Myers CE. Young RC, et al. N Engl J Med. 1981 Jul 16;305(3):139-53. doi: 10.1056/NEJM198107163050305. N Engl J Med. 1981. PMID: 7017406 Review. No abstract available.